Clinical trial updates

December 22, 2023

SP-420

Read More »
August 21, 2023

CASGEVY™ (gene editing)

Read More »
August 21, 2023

INTERCEPT™(pathogen inactivation)

Read More »
August 20, 2023

Hemanext ONE®

Read More »
August 20, 2023

Ferriprox®

Read More »
August 20, 2023

ST-400 (gene editing)

Read More »
August 20, 2023

reni-cel (EDIT-301)

Read More »
August 20, 2023

Reblozyl®

Read More »
August 18, 2023

ZYNTEGLO™ (gene therapy)

Read More »
August 17, 2023

MWTX-003

Read More »

Next page